Underweight: Trim to 50-60% benchmark weight via phased execution; Q3 2026 earnings catalyst 4-6 weeks out
All three analysts converge on Underweight direction. The negative book equity (-$5.7B), 4.2x leverage, -89% YoY H1 FCF, accelerating SG&A (+88.5% YoY in Q2), and CEO credibility overhang create structural headwinds that override the defended floor doctrine. The phased trim architecture resolves past failure modes: sized enough to capture the downtrend direction, structured enough (put spread hedge, defined stops) to survive a Q3 surprise. Do NOT initiate new longs in the $155-$170 range. The binding lesson mandates that when fresh fundamentals explicitly contradict the structural-floor defense, the override should escalate to Underweight/short rather than splitting the difference.
| Position | Action |
|---|---|
| Current levels (~$163) | Trim 30-40% of benchmark weight |
| Rally into $167-$169 resistance zone | Trim another 20-30% of benchmark weight |
| Residual exposure after phased trim | Hedge with January 2027 $150/$130 put spread |
HONA at $163.33 is being handed to patient capital ahead of a re-rating; forward EPS of $9.09 versus TTM EPS of $3.28 represents a ~177% implied earnings recovery, with technicals telegraphing a base completion and breakout setup.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 162.83 | bullish |
| 50 SMA | 177.23 | bearish |
| 200 SMA | 193.26 | bearish |
| RSI (14) | 47.95 | neutral |
| MACD | -2.74 | bullish |
| MACD Signal | -5.20 | bullish |
| MACD Histogram | +2.46 | bullish |
| ATR (14) | 7.39 | bullish |
| Bollinger Upper | 169.78 | neutral |
| Bollinger Mid | 159.86 | neutral |
| Bollinger Lower | 149.94 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed daily close >$170 on ≥5M shares
Then: Re-evaluate for upgrade to Hold/Overweight
↩ rebuts: “The 90-day drawdown of -37% confirms the downtrend”
EV: +22% to +33% · concedes: Forward P/E of 18x is not a screaming buy on its own; 4.2x leverage is elevated and requires monitoring; CEO credibility overhang exists and requires a clean Q3 print to clear; Supply constraints will take time to resolve despite being a pricing power story
HONA is a distressed story trading like a healthy one—the risk/reward is asymmetric against the long (1:1.5 reward-to-risk favoring the short), the technicals are forming lower highs within the base, the financial structure is genuinely distressed with 4.2x leverage and negative equity, and management credibility will not be repaired before the next major catalyst in 5-6 weeks.
· concedes: The squeeze is real, the MACD cross is real, the RSI recovery is real — but none of them overcome the primary trend until price reclaims the 50 SMA on volume with a catalyst not expected for 5-6 weeks (Q3 earnings late October/early November); GE +3.1% on Currier's validation is a sector tailwind — though GE's multiple expansion comes from strategic action (acquiring CPP), while HONA's multiple stays compressed due to strategic inaction
→ vs neutral: Calls the 'oversold bounce within a downtrend' framing 'pattern-matching comfort food' — the neutral analyst acknowledged lower highs and descending 50 SMA yet recommended HOLD, which the aggressive analyst labels 'cognitive dissonance'
→ vs neutral: Argues the neutral analyst's own report admits the bear case without committing to it by stating 'burden of proof shifted to management' and expecting 'follow-through pressure' — if you believe what you write, you sell
→ vs conservative: Dismisses S&P sub-index inclusion as creating only 'tens of millions of dollars' in passive demand versus permanent exclusion from institutional buyer universe due to negative book value — calls this 'selectively cautious in the wrong direction'
→ vs conservative: Challenges the 'clean quarter ahead' assumption — Q2 was a 'step-change worse than Q1,' and there's no basis to expect improvement when the trajectory is worsening
→ vs conservative: Contends HOLD is not being cautious but 'slow' — paying cost of carry on a deteriorating position while waiting for confirmation of a trend already in motion
→ vs neutral: Technical squeeze (ATR $7.39, Bollinger Bands $20) resolves down more often when directional bias is clearly down; lower-highs pattern is the tiebreaker pointing lower, and buying a squeeze under descending 50 SMA is 'fighting the trend with a prayer'
| Volume | 2,973,367 | neutral |
Support: 159.86 · 149.94 | Resistance: 169.78 · 177.23 · 193.26
The stock shows a textbook post-capitulation base with the tightest Bollinger Band width in 90 days (~20 points), suggesting an imminent directional resolution. The primary bullish catalysts are a confirmed MACD crossover and a rising 10 EMA above price, while the bearish headwinds include price remaining below both the 50 SMA and 200 SMA with both moving averages in downward trajectories. The recommended stance is HOLD with a tactical bullish bias—advocating longs inside the $155–$168 zone with tight stops, and adding positions on a confirmed daily close above $170 with volume ≥5M, while avoiding long exposure entirely on a break below $150.
Market Cap
$51.77B
P/E (TTM)
49.80x
Forward P/E
17.97x
PEG Ratio
1.07
P/B
-9.09x
EV/EBITDA (implied)
~18.8x
EPS (TTM)
$3.28
Forward EPS
$9.09
Book Value/Share
-$17.97
Revenue (TTM)
$17.92B
Gross Profit (TTM)
$6.19B
EBITDA (TTM)
$3.54B
Net Income (TTM)
$1.95B
Operating Margin (TTM)
14.68%
Net Margin (TTM)
10.86%
Total Assets
$19.37B
Total Liabilities
$24.99B
Stockholders' Equity
-$5.70B
Long-Term Debt
$15.85B
Net Debt
$14.79B
Cash & Equivalents
$1.06B
Current Ratio
1.526
Net Debt / EBITDA
~4.2x
Operating Cash Flow (Q2 2026)
$571M
CapEx (Q2 2026)
-$123M
Free Cash Flow (Q2 2026)
$448M
D&A (quarterly run rate)
$122M
Revenue Growth (Q2 2026 YoY)
+5.4%
Operating Income Growth (Q2 2026 YoY)
-33.3%
Net Income Growth (Q2 2026 YoY)
-70.9%
EPS Growth (Q2 2026 YoY)
-70.7%
52-Week High
$297.50
52-Week Low
$149.19
50-Day Moving Average
$177.31
200-Day Moving Average
$193.32
Shares Outstanding
~316.9M
Interest Expense (Q2 2026)
$200M
Tax Rate (Q2 2026)
32.3%
SG&A (Q2 2026)
$722M
Restructuring Charges (Q2 2026)
$74M
Inventory (Q2 2026)
$4.47B
Working Capital
$3.39B
Strengths
Concerns
Honeywell Aerospace Inc. (HONA) is a recently spun-off Aerospace & Defense company with a high-quality underlying franchise but significant post-separation transition noise. Q2 2026 earnings were severely compressed (-70.9% YoY net income decline) due to $200M quarterly interest expense on $15.84B of new debt, normalized 32.3% tax rate, and 88.5% SG&A inflation from public-company stand-up costs. The balance sheet reflects expected spin-off stress with negative $5.7B stockholders' equity and 4.2x net leverage, though liquidity remains adequate with $1.06B cash and 1.53x current ratio. With 18x forward P/E on normalized $9.09 EPS (vs 49.8x trailing), the stock offers reasonable upside if H2 2026 margin recovery materializes as separation costs roll off and the company converges toward 22-25% normalized operating margins.
Macro: Fed rate policy shows 96% implied probability of no rate cuts in 2026 (+1.7pp week-over-week), with all cut scenarios (9, 10, 11, 12+ cuts) priced at 0%. US recession probability by end of 2026 stands at 8% (-4.0pp week-over-week), UK at 12% (+4.0pp), Japan at 4% (-2.0pp). Low recession odds support the commercial aerospace cycle (airlines keep flying, MRO demand elevated); defense budgets are countercyclical. FRED macro data (CPI, fed funds, 10Y yield, yield curve) was unavailable due to vendor-side credentialing limitation.